Increased plasma concentration of fibrin monomer in acute myocardial infarction with early reperfusion

Coronary Artery Disease

Volumn 7, Issue 2, 1996, Pages 155-160

  Spiecker, Martin ^a   Hafner, Gerd ^a   Nixdorff, Uwe ^a   Prellwitz, Winfried ^a   Meyer, Jürgen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

fibrin monomer; myocardial infarction; reperfusion; thrombin activity

Indexed keywords

FIBRIN MONOMER; HEPARIN; THROMBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0030058467     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199602000-00010     Document Type: Article

References (28)

1. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE: Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987, 317:1361-1365.
2. Nieuwenhuizen W, Hoegee-de Nobel E, Laterveer R: A rapid monoclonal antibody-based immunoassay (EIA) for the quantitative determination of soluble fibrin in plasma. Thromb Haemost 1992, 68:273-277.
3. Dempfle CE, Dollman M, Lill H, Mühlhofer W, Dessauer A, Heene DL: Activation parameters of blood coagulation in medical and surgical patients developing DVT: evaluation of a new fibrin monomer ELISA [abstract]. Thromb Haemost 1993, 69:1004.
4. Hansson PO, Eriksson H, Eriksson E, Jagenburg R, Lukes P, Risberg B: Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit? J Intern Med 1994, 235:143-151.
5. Okajima K: Determination of fibrin monomers in patients with DIC; its usefulness for early detection of the hypercoagulable state [abstract]. Ann Hematol 1993, 66 (suppl 1):A6.
6. Slaughter TF, LeBleu TH, Douglas JM Jr, Leslie JB, Parker JK, Greenberg CS: Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994, 80:520-526.
7. Sorensen JV, Rahr HB, Jensen HP, Borris LC, Lassen MR, Ejstrud P: Markers of coagulation and fibrinolysis after fractures of the lower extremities. Thromb Res 1992, 65:479-486.
8. Vogel G, Spanuth E: Predictive value of fibrin monomers in postoperative deep vein thrombosis. Klin Wochenschr 1990, 68:1020-1026.
9. Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Otenloch-Haehnle B, et al.: A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation activity in vivo. Blood Coagul Fibrinolysis 1993, 4:97-102.
10. Spannagl M, Trauner A, Birg A, Frank G, Hoffmann H, Siebeck M, et al.: Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay. Blood Coagul Fibrinolysis 1993, 4:103-106.
11. Dempfle CE, Dollmann M, Lill H, Puzzovio D, Dessauer A, Heene DL: Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Blood Coagul Fibrinolysis 1993, 4:79-86.
12. Eisenberg PR, Sherman L, Schectman K, Perez J, Sobel BE, Jaffe AS: Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation 1985, 71:912-918.
13. Johnsson E, Orinius K, Paul C: Fibrinopeptide A (FPA) in patients with acute myocardial infarction. Thromb Res 1979, 16:255-261.
14. Mombelli G, im Hof V, Haeberli A, Straub PW: Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. Circulation 1984, 69:684-689.
15. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993, 329:1615-1622.
16. Hogg PJ, Jackson CM: Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc Natl Acad Sci USA 1989, 86:3619-3623.
17. Hotchkiss KA, Chesterman CN, Hogg PJ: Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. Blood 1994, 84:498-503.
18. Andersen JL, Marshall HW, Bray BE, Lutz JR, Frederick PR, Yanowitz FG, et al.: A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 1983, 308:1312-1318.
19. Remppis A, Scheffold T, Karrer O, Zehelein J, Hamm C, Grunig E. et al.: Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J 1994, 71:242-248.
20. Oehler G, Klaus H, Spanuth E: Erfahrungen mit einem Fibrinmonomertest bei der Diagnose der Verbrauchskoagulopathie . In Neue Aspekte der Gerinnungsdiagnostik. Edited by Roka L, Spanuth E. Stuttgart: FK Schattauer Verlag; 1984:109-120.
21. Seifried E, Transwell P, Ellbruck D, Haerer W, Schmidt A: Pharmacokinetics and hemostatic status during consecutive infusions of recombinant tissue type plasminogen activator In patients with acute myocardial infarction. Thromb Haemost 1989, 61:497-501.
22. Eisenberg PR, Sherman LA, Jaffe AS: Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol 1987, 10:527-529.
23. Eisenberg PR, Miletich JP: Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood. Thromb Res 1989, 55:635-643.
24. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER: Thrombolytic therapy with tissue plasminogen activator or streptokinase Induces transient thrombin activity. Blood 1988, 72:616-620.
25. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M, et al.: Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1995, 25:203-209.
26. Eisenberg PR, Sobel BE, Jaffe AS: Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992, 19:1065-1069.
27. Garcia-Avello A, Garcia-Frade LJ, Gandarias C, Ocana J, Cancelas JA, Lasso M: High F 1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA. Thromb Res 1994, 73:109-115.
28. Haskel EJ, Eisenberg PR, Abendschein DR: Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood. Blood Coagul Fibrinolysis 1993, 4:7-13.